author-photo

Gallen Triana-Baltzer

Janssen Pharmaceutica

9

Papers

150

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Development and validation of a high-sensitivity assay for measuring p217+tau in plasma.

2021 Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Show All
- Source
- Cite
- Save
Citations (0)
Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody

2020 Journal of Alzheimer's Disease
Show All
- Source
- Cite
- Save
Citations (5)
Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid.

2020 Journal of Alzheimer's Disease
Show All
- Source
- Cite
- Save
Citations (6)
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (107)
A SINGLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF THE ANTI-PHOSPHO-TAU ANTIBODY JNJ-63733657 IN HEALTHY SUBJECTS

2019 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (5)
Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

2018 Journal of Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (19)
307. Potential Biomarkers of Impending Schizophrenia Relapse: Exploratory Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase-3 Study of Paliperidone Palmitate 3-Month Formulation

2017 Biological Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
P301L TAU DEMONSTRATES ALTERED MODULATION OF CALMODULIN-DEPENDENT PDE1 AND CALCINEURIN IN VITRO

2016 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)